Understanding how these incretin-based therapies interact with your gastrointestinal system helps explain their common digestive side effects
Some approaches include: BCL-2/BCL-xL inhibitors (e.g., navitoclax), tyrosine kinase inhibitors, metabolic stressors, or even immune-based clearance
No, semaglutide is not a reason for deferral
The role of the immune system in Huntingtons disease
if cloudiness remains, the vial is warmed in a closed hand and swirled again
By paying attention to it, we uncovered one of the most powerful tools for metabolic health and longevity that medicine has identified. For many people on GLP-1s, the experience has been quietly validatingconfirming that what they were missing wasnt willpower but the biological switch that silences food noise, a discovery that traces all the way back to the Gila monster.